Cell Therapeutics proposes private placement of preferred stock

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash.
Business: Cancer

Read the full 91 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE